Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

Here, we present the case of a 64-year-old male patient diagnosed with castration-resistant prostate cancer (CRPC) with bone metastasis, treated with abiraterone prednisone/prednisolone in combination with 223Ra-dichloride therapy, who had remission and a subsequent relapse of bone metastasis on rep...

Full description

Bibliographic Details
Main Authors: Anna Maria Mangano, Massimiliano Pacilio, Pasquale Ialongo, Alessandro Semprebene, Guido Ventroni, Lucio Mango
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:Diagnostics
Subjects:
prostate cancer
bone scan
bone metastasis
223Ra-dichloride therapy
Online Access:http://www.mdpi.com/2075-4418/8/1/18

Internet

http://www.mdpi.com/2075-4418/8/1/18

Similar Items